Here are the DEF 14A proxy statements from Inception Growth Acq Ltd (IGTA) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow IGTA and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full IGTA filings page.
Inception Growth Acquisition Limited is asking stockholders to approve amendments that would extend the deadline to complete a business combination from August 13, 2026 to February 13, 2027, via up to six one‑month extensions. Each extension would require depositing $0.05 per unredeemed IPO Public Share into the Trust Account as an interest‑free loan from the sponsor, repayable only if a deal closes.
As of July 29, 2026, the Trust Account held about $2,207,000, giving an estimated redemption price of $13.57 per Public Share, while the Public Shares traded on the OTC Markets at $0.0011. Holders may redeem regardless of how they vote, but redeemed shares lose future upside and voting rights.
The company’s securities were delisted from Nasdaq after missing the 36‑month SPAC deadline and now trade on the OTC Markets, with potential “penny stock” and state blue-sky limitations. The proxy also highlights constraints from CFIUS review because the sponsor is foreign‑controlled and the risk of Investment Company Act issues if funds remain invested in government securities for an extended period. If no extension and no business combination occur by August 13, 2026, the company will liquidate, return Trust funds to public stockholders, and warrants and rights will expire worthless.
Inception Growth Acquisition Limited is asking stockholders to approve amendments to its charter and trust agreement to extend the deadline to complete a business combination from February 13, 2026 to up to August 13, 2026, in six one‑month steps. For each extra month, the sponsor or its affiliates intend to lend the company an amount equal to $0.075 per public share not redeemed, to be deposited into the trust account and repaid only if a deal closes. Public stockholders may redeem their shares for cash; as of January 16, 2026, the estimated redemption price was about $12.75 per share, based on approximately $2,250,589.54 held in the trust account. If the extensions are fully used and no further redemptions occur, the company estimates a future redemption value of about $13.20 per share. The company’s securities have been delisted from Nasdaq for failing to complete a merger within 36 months and now trade on the OTC Markets, which may limit liquidity. If the extension proposals are not approved and no business combination is completed by February 13, 2026, the company will liquidate the trust and public warrants and rights will expire worthless.